AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
107 hedge funds and large institutions have $125M invested in Accelerate Diagnostics in 2021 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 45 increasing their positions, 24 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
10% less capital invested
Capital invested by funds: $138M → $125M (-$13.5M)
92% less call options, than puts
Call options by funds: $109K | Put options by funds: $1.29M
Holders
107
Holding in Top 10
3
Calls
$109K
Puts
$1.29M
Top Buyers
| 1 | +$2.09M | |
| 2 | +$1.78M | |
| 3 | +$1.77M | |
| 4 |
Two Sigma Advisers
New York
|
+$1.62M |
| 5 |
Two Sigma Investments
New York
|
+$1.48M |
Top Sellers
| 1 | -$3.44M | |
| 2 | -$2.93M | |
| 3 | -$1.78M | |
| 4 |
SM
Selkirk Management
Chatham,
New Jersey
|
-$1.53M |
| 5 |
GAM
Griffin Asset Management
New York
|
-$1.27M |